Skip to content

CoRoent 6171060Recalls & reported problems

Nuvasive, Inc. · CoRoent® XLFW, 10x22x60mm Lordotic · Class 2 · Implant

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00887517292773), received between Mar 18, 2024 and Mar 18, 2024 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Bacterial Infection1
  • Pain1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 18, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE PATIENT UNDERWENT AN INITIAL TWO (2) LEVEL EXTREME LATERAL INTERBODY FUSION PROCEDURE FROM L3 TO L5 WITH PERCUTANEOUS POSTERIOR FIXATION. SUBSEQUENTLY, APPROXIMATELY SIX (6) WEEKS LATER, IT WAS NOTED THAT THE PATIENT HAD SUFFERED POSTOPERATIVE COMPLICATIONS THAT REQUIRED SEQUENTIAL RE-OPERATIONS INCLUDING A STAPHYLOCOCCUS INFECTION, PAIN, AND CANAL COMPRESSION. INFORMATION REGARDING THE DATE(S), QUANTITY, AND NATURE OF THE RE-OPERATIONS WAS NOT PROVIDED; HOWEVER, IT WAS NOTED THAT THE PATIENT UNDERWENT A REVISION PROCEDURE TO REMOVE THE L3/L4 INTERBODY VIA AN ANTERIOR APPROACH AND REPLACE WITH AN ANTERIOR LUMBAR INTERBODY FUSION WITH INTERFIXATION. FOLLOWING THE REVISION, IT WAS NOTED THAT THE PATIENT HAD ABDOMINAL BLEEDING AND WAS TRANSFERRED TO ANOTHER HOSPITAL FOR TREATMENT. ADDITIONAL INFORMATION REPORTED THE PATIENT'S CONDITION HAS IMPROVED. THE SURGEON DOES NOT BELIEVE THE COMPLICATIONS WERE RELATED TO THE PRODUCTS USED. NO FURTHER PATIENT IMPACT WAS REPORTED. NO ADDITIONAL INFORMATION IS AVAILABLE.

    Patient problems: Bacterial Infection; Pain

    MAUDE report 18927274 ↗

Other Intervertebral fusion device with bone graft, cervical devices

All Intervertebral fusion device with bone graft, cervical devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.